Mosaic Biosciences

About

Mosaic Biosciences is a developer of synthetic extracellular materials used to support natural tissue regeneration.

Boulder,Colorado,United States
11 - 50
http://mosaicbio.com

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $11.40M
Industries: Biotechnology,Medical,Therapeutics
Founded date: Jan 1, 2009
Number Of Employee: 11 - 50
Operating Status: Active

Mosaic Biosciences is a developer of synthetic extracellular materials used to support natural tissue regeneration. With its proprietary platform technology, Mosaic expects to significantly impact the field of tissue regeneration, including applications in wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers.

The company's products are based on a novel and patented technology platform that can be used to develop synthetic extracellular matrices for support of natural tissue regeneration. These 3-dimensional scaffolds are designed to have the specific biophysical and biochemical properties necessary to support native tissue structures and promote new tissue formation.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$14.67M

Mosaic Biosciences has raised a total of $14.67M in funding over 2 rounds. Their latest funding was raised on Jun 14, 2022 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 14, 2022	Series Unknown	$11.40M	2	Telegraph Hill Partners	—	Detail
Feb 10, 2014	Series Unknown	$2.27M	—	—	—	Detail
Nov 8, 2011	Series A	$1M	3	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

5

Mosaic Biosciences is funded by 5 investors. Telegraph Hill Partners and Dan Mitchell are the most recent investors.

Investor Name	Lead Investor	Funding Round
Telegraph Hill Partners	Yes	Series Unknown
Dan Mitchell	—	Series Unknown
HealthCare Ventures	—	Series A
High Country Venture	—	Series A
Morgenthaler Ventures	—	Series A